Treatments for Neurodegenerative Disorders to hit $17 billion, Says a New Report Available From Piribo.com
Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on the neurodegenerative disorder therapies market. "The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007" forecasts that the overall neurodegenerative market will grow from around $9 billion in 2005 to more than $17 billion by 2010.
The overall neurodegenerative market is growing at over 12% each year. With an increase in life expectancy and the number of old people, along with advances in treatments of neurodegenerative diseases this looks set to continue.
The market for Alzheimer's therapy alone is expected to rise from $4 billion in 2005 to $6.8 billion in 2010 with the US market continuing to dominate. The Parkinson's market is anticipated to grow at a greater rate over the next few years due to the use of second generation dopamine agonists in the treatment of early stage patients.
In addition, this report looks at driving growth behind the Multiple Sclerosis and Neuropathy market, forecasting areas of particular expansion. It also looks at challenges facing the growing neurodegenerative market, including reviews by NICE, UK and current Research and Development work.
Key features of this report:
| | - Statistical information for selected neurological diseases
- Overview of the disease, key therapies, market size and growth, market composition by region, as well as market outlook and forecast
- Global sales figures for key neurodegenerative therapies
- Financial forecasts by disease and key product
- Description of neurotherapeutic products currently on the market, including a description of products in the pipeline
- Company profiles of major pharmaceutical providers active in R&D in these areas
- The report also deals with factors affecting growth, new drug therapies, and clinical research in the completion stages.
|
The diseases/conditions addressed in the report include:
| | - Alzheimer's disease
- Parkinson's disease
- Multiple sclerosis
- Amyotrophic lateral sclerosis
- Huntington's disease
- Neuropathies
|
This comprehensive report is vital for any information buyer who needs incisive detail on this developing market.
"The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007" is available in pdf format from Piribo. For more information, go to: http://www.piribo.com/publications/therapeutic/cns_neurology/global_market_and_future_outlook_for_neurodegenerative_disorder_therapies_2007.html
Piribo product ID: ARR019
About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 6,000 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.
###
|
